Cronos Group Inc (NASDAQ:CRON)

21.69
Delayed Data
As of Mar 18
 +0.69 / +3.29%
Today’s Change
5.12
Today|||52-Week Range
25.10
+108.76%
Year-to-Date
Cronos Group's $1.8 Billion Investment From Altria Has Closed. Now What?
Mar 17 / MotleyFool.com - Paid Partner Content
Cronos Group (CRON) Stock Sinks As Market Gains: What You Should Know
Mar 13 / Zacks.com - Paid Partner Content
Do Top Marijuana CEOs Put Their Money Where Their Mouth Is?
Mar 17 / MotleyFool.com - Paid Partner Content
Why Marijuana Stock Cronos Group Has Skyrocketed 104% So Far in 2019
Mar 12 / MotleyFool.com - Paid Partner Content
Here's the Real Reason Aurora Cannabis Shares Caught Fire Yesterday
Mar 14 / MotleyFool.com - Paid Partner Content
Altria Focuses on RRPs Growth, Closes Investment in Cronos
Mar 11 / Zacks.com - Paid Partner Content
3 Pot Stocks Wall Street Thinks You Should Sell
Mar 14 / MotleyFool.com - Paid Partner Content
A Massive Disruption Could Be on the Way for Marijuana: 3 Stocks Poised to Profit
Mar 10 / MotleyFool.com - Paid Partner Content
3 Top Marijuana Stocks to Watch in March
Mar 14 / MotleyFool.com - Paid Partner Content
Here's Canopy Growth's Top Rival (Hint: It Isn't Aurora Cannabis, Cronos Group, or Ti...
Mar 10 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close21.00
Today’s open21.00
Day’s range20.99 - 21.75
Volume6,403,077
Average volume (3 months)14,396,241
Market cap$6.9B
Data as of 4:15pm ET, 03/18/2019

Growth & Valuation

Earnings growth (last year)+174.49%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+608.57%
P/E ratioNM
Price/Sales437.01
Price/Book45.37

Competitors

 Today’s
change
Today’s
% change
ARGXargenx SE+1.53+1.16%
APHAAphria Inc+0.64+6.67%
USNAUSANA Health Science...-0.71-0.77%
HEXOHexo Corp+0.62+10.15%
Data as of 8:00pm ET, 03/18/2019

Financials

Next reporting dateMarch 26, 2019
EPS forecast (this quarter)-$0.00
Annual revenue (last year)$3.1M
Annual profit (last year)$1.9M
Net profit margin61.02%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Michael Gorenstein
Chief Operating Officer
David Hsu
Corporate headquarters
Toronto, Ontario

Forecasts